Logo image of TLRY

TILRAY BRANDS INC (TLRY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TLRY - US88688T2096 - Common Stock

11.16 USD
-1.18 (-9.56%)
Last: 12/19/2025, 8:18:39 PM
11.17 USD
+0.01 (+0.09%)
After Hours: 12/19/2025, 8:18:39 PM
Fundamental Rating

2

Overall TLRY gets a fundamental rating of 2 out of 10. We evaluated TLRY against 191 industry peers in the Pharmaceuticals industry. TLRY may be in some trouble as it scores bad on both profitability and health. TLRY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TLRY had negative earnings in the past year.
TLRY had a negative operating cash flow in the past year.
TLRY had negative earnings in each of the past 5 years.
TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY Yearly Net Income VS EBIT VS OCF VS FCFTLRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

The Return On Assets of TLRY (-103.13%) is worse than 80.10% of its industry peers.
Looking at the Return On Equity, with a value of -139.41%, TLRY is doing worse than 68.06% of the companies in the same industry.
Industry RankSector Rank
ROA -103.13%
ROE -139.41%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY Yearly ROA, ROE, ROICTLRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

TLRY has a Gross Margin (28.69%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TLRY has grown nicely.
TLRY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY Yearly Profit, Operating, Gross MarginsTLRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLRY has been increased compared to 1 year ago.
The number of shares outstanding for TLRY has been increased compared to 5 years ago.
The debt/assets ratio for TLRY is higher compared to a year ago.
TLRY Yearly Shares OutstandingTLRY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
TLRY Yearly Total Debt VS Total AssetsTLRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

TLRY has an Altman-Z score of -1.14. This is a bad value and indicates that TLRY is not financially healthy and even has some risk of bankruptcy.
TLRY has a Altman-Z score of -1.14. This is comparable to the rest of the industry: TLRY outperforms 43.46% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that TLRY is not too dependend on debt financing.
TLRY has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.14
ROIC/WACCN/A
WACC8.29%
TLRY Yearly LT Debt VS Equity VS FCFTLRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.62 indicates that TLRY has no problem at all paying its short term obligations.
With a Current ratio value of 2.62, TLRY perfoms like the industry average, outperforming 46.60% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that TLRY should not have too much problems paying its short term obligations.
TLRY has a worse Quick ratio (1.56) than 60.21% of its industry peers.
Industry RankSector Rank
Current Ratio 2.62
Quick Ratio 1.56
TLRY Yearly Current Assets VS Current LiabilitesTLRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

TLRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6498.00%.
TLRY shows a small growth in Revenue. In the last year, the Revenue has grown by 2.31%.
TLRY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.52% yearly.
EPS 1Y (TTM)-6498%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)2.31%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%4.73%

3.2 Future

Based on estimates for the next years, TLRY will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.94% on average per year.
The Revenue is expected to grow by 4.31% on average over the next years.
EPS Next Y99.61%
EPS Next 2Y41.34%
EPS Next 3Y25.98%
EPS Next 5Y14.94%
Revenue Next Year3.65%
Revenue Next 2Y4.08%
Revenue Next 3Y4.24%
Revenue Next 5Y4.31%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TLRY Yearly Revenue VS EstimatesTLRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
TLRY Yearly EPS VS EstimatesTLRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TLRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY Price Earnings VS Forward Price EarningsTLRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

78.53% of the companies in the same industry are more expensive than TLRY, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.76
TLRY Per share dataTLRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

TLRY's earnings are expected to grow with 25.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.34%
EPS Next 3Y25.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLRY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

TILRAY BRANDS INC

NASDAQ:TLRY (12/19/2025, 8:18:39 PM)

After market: 11.17 +0.01 (+0.09%)

11.16

-1.18 (-9.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-09 2025-10-09/bmo
Earnings (Next)01-08 2026-01-08/bmo
Inst Owners10.33%
Inst Owner Change21.11%
Ins Owners0.36%
Ins Owner Change2.64%
Market Cap1.29B
Revenue(TTM)830.77M
Net Income(TTM)-2.15B
Analysts71.25
Price Target17.2 (54.12%)
Short Float %N/A
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2631.48%
Min EPS beat(2)-5362.97%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-1385.84%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)2
Avg EPS beat(8)-708.23%
EPS beat(12)2
Avg EPS beat(12)-746.7%
EPS beat(16)4
Avg EPS beat(16)-606.4%
Revenue beat(2)1
Avg Revenue beat(2)-3.41%
Min Revenue beat(2)-7.23%
Max Revenue beat(2)0.41%
Revenue beat(4)1
Avg Revenue beat(4)-6.19%
Min Revenue beat(4)-13.28%
Max Revenue beat(4)0.41%
Revenue beat(8)1
Avg Revenue beat(8)-5.71%
Revenue beat(12)2
Avg Revenue beat(12)-3.59%
Revenue beat(16)2
Avg Revenue beat(16)-3.93%
PT rev (1m)810.09%
PT rev (3m)1562.73%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-788.89%
EPS NY rev (1m)-19.05%
EPS NY rev (3m)54.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.7
EV/EBITDA 33.76
EPS(TTM)-13.2
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.83
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS7.16
BVpS13.28
TBVpS6.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -103.13%
ROE -139.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.69%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 6.5
Cap/Depr 30.45%
Cap/Sales 4.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.62
Quick Ratio 1.56
Altman-Z -1.14
F-Score3
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6498%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y99.61%
EPS Next 2Y41.34%
EPS Next 3Y25.98%
EPS Next 5Y14.94%
Revenue 1Y (TTM)2.31%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%4.73%
Revenue Next Year3.65%
Revenue Next 2Y4.08%
Revenue Next 3Y4.24%
Revenue Next 5Y4.31%
EBIT growth 1Y28.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.61%
EBIT Next 3Y29.12%
EBIT Next 5Y17.36%
FCF growth 1Y-688.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-258.17%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.


What is the valuation status of TILRAY BRANDS INC (TLRY) stock?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY). This can be considered as Overvalued.


How profitable is TILRAY BRANDS INC (TLRY) stock?

TILRAY BRANDS INC (TLRY) has a profitability rating of 1 / 10.


How financially healthy is TILRAY BRANDS INC?

The financial health rating of TILRAY BRANDS INC (TLRY) is 3 / 10.